Introduction
Association between a de®ned subset of chromosomal translocations and a given type of hematopoietic malignancy is recurrently observed, strongly suggesting a role of speci®c karyotypic rearrangements in the etiology of the disease. Supporting this view, molecular analyses have shown in many cases that the translocation event generates speci®c gene alterations, (reviewed in Drexler et al., 1995) . In a ®rst mechanism typi®ed by the Burkitt's lymphoma, a protooncogene is cisactivated by regulatory sequences (in most cases from the antigen receptor genes) contributed by the translocated chromosome. Gene fusion is a more complex genetic rearrangement that can also arise from translocation. In this case, the two reciprocal chimera may be altered in both their expression and their activity, as compared to the non rearranged parental genes. Gene fusion so far found both in hematopoietic cancers and in sarcomas, occurs in Acute Promyelocytic Leukemia (APL). In the three documented translocations associated with APL, a common breakpoint in chromosome 17 disrupts the Retinoic Acid Receptor a (RARa) gene (Borrow et al., 1990; Chen et al., 1993; de TheÂ et al., 1990; Redner et al., 1996) . This strongly suggests a role of this speci®c RARa gene alteration in the block of malignant cells at an immature stage. In more than 90% of APL cases, the other breakpoint involves the PML gene (chromosome 15), encoding a ring ®nger protein of unknown function that results in the expression of the PMLRARa fusion protein in leukemic cells Kakizuka et al., 1991; Kastner et al., 1992; Pandol® et al., 1991) . Clinical remission of t(15;17) APL can be induced by all trans retinoic acid (ATRA) therapy (Castaigne et al., 1990; Huang et al., 1988) which appears to fully relieve the dierentiation block of malignant cells.
The mechanisms underlying reversibility of the transformed phenotype, a so far unique property among leukemias has focused much attention. Two major alterations have been discerned in t(15;17) APL cells. At the molecular level, the chimeric PML-RARa protein antagonizes wild type RARa in retinoic acid-regulated transcription Kakizuka et al., 1991; Kastner et al., 1992; Pandol® et al., 1991; Perez et al., 1993) . At the cellular level, the subnuclear structures termed PML bodies, in which PML resides in normal cells, are disorganized in leukemic cells leading to mislocalization of PML in microspeckled structrues (Daniel et al., 1993; Dyck et al., 1994; Kastner et al., 1992; Koken et al., 1994; Weis et al., 1994) . Interestingly, ATRA-induced dierentiation restores both PML body structure and RARa function (Daniel et al., 1993; Dyck et al., 1994; Kastner et al., 1992; Koken et al., 1994; Rousselot et al., 1994; Weis et al., 1994) .
In a rare variant APL associated with t(11;17), the RARa gene is fused to the PLZF gene (Chen et al., 1993) which encodes a protein with a putative DNAbinding domain of 9 Zinc-®nger motifs in its carboxyterminal region ( Figure 1A ). Leukemic cells express a PLZF-RARa chimeric protein, ( Figure 1B ) that like PML-RARa, interferes with wild type RARa function Licht et al., 1996) . However, t(11;17) APL is resistant to both chemotherapy and to ATRA therapy Licht et al., 1995) . Interestingly, the reciprocal RARa chimeric gene encoding the RARa-PLZF fusion protein is also expressed in the t(11;17) associated syndrome (Chen et al., 1993) . The hybrid protein consists of the A region from RARa, known to be a ligand-independent transactivation domain (Leroy et al., 1991) fused to the 7 carboxyterminal Zinc-®ngers of PLZF ( Figure 1B) . Expression of wild type PLZF has been shown to decrease upon dierentiation of hematopoietic precursors (Reid et al., 1995) ; therefore, if RARa-PLZF behaves as an autonomous functional transcription factor, its inappropriate expression driven by the natural RARa gene promoter might contribute to the refractory of leukemic cells to ATRA.
In a yeast two-hybrid (Fields and Song, 1989 ) screening experiment, we isolated clones encoding various parts of PLZF fused to the GAL4 activation domain. In the present work, we took advantage of these hybrid genes to investigate the functional properties of PLZF. We show that the last 5 Zinc®ngers of PLZF, retained in the t(11;17)-speci®c RARa-PLZF fusion are sucient for DNA-binding activity and can lead transcriptional activation in human cells when fused to a heterologous activation domain. We also delineate a PLZF-speci®c target sequence. Altogether, our data suggest that RARa-PLZF may contribute to malignant transformation or maintenance of leukemic phenotype in t(11;17) APL via abnormal expression of PLZF target genes.
Results and discussion
Isolation of GAL4 activation domain -PLZF hybrid genes in a yeast two-hybrid screen
In an attempt to identify human proteins interacting with the human hepatitis B virus X protein (HBx), we performed the following yeast two-hybrid screening: a L40-derived yeast strain (Hollenberg et al., 1995) expressing LexA fused to HBx (bait protein) was transformed with DNA from a library of human liver cDNAs fused to the GAL4 activation domain sequence (prey plasmids). Of the 5 million yeast transformants produced, about 2000 colonies grew in minus-histidine selective medium as a result of his3 reporter gene activation. The prey plasmid was rescued from 7 his + colonies showing strong lacZ In this model, the PLZF Zinc-®nger domain binds to upstream elements of the reporter gene. As a result, the fused GAL4 activation domain contracts the transcriptional machinery which in turn activates transcription reporter activation, as detected by appearance of blue staining in the presence of X-GAL within 1 h at 308C. When re-transformed into L40 yeast strain, one prey plasmid showed reporter gene activation speci®c for the HBx bait protein (to be reported elsewhere). The six others conferred his3 and lacZ activation regardless of the co-transformed bait plasmid. Remarkably, these plasmids also conferred strong growth inhibition to the transformed yeast cells which prompted us to determine the nucleotide sequence of their cDNA inserts. All inserts were partial cDNA copies of PLZF mRNA fused in frame with the GAL4 activation domain sequence and fell into three classes of clones ( Figure 1C ). ACT-PLZF 1 (one isolate) represents the shortest cDNA encoding the PLZF region from AA residue 506 to 673 which includes the 5 most carboxyterminal Zinc-®ngers of the protein. ACT-PLZF 2 (4 isolates) encodes amino acids 398-673, encompassing the 9 Zinc-®nger region of the protein. The longest cDNA (ACT-PLZF 3; one isolate) encodes residues 283-673 of the protein, including the Zinc-®nger region and part of the Nterminal proline-rich domain. These PLZF hybrids are strikingly similar in structure to the RARa-PLZF fusion arising in t(11;17) associated APL (Chen et al., 1993) ; RARa-PLZF contains the 7 carboxyterminal PLZF Zinc-®ngers and harbors a constitutive transcriptional activation domain provided by the RARa portion (Leroy et al., 1991) ( Figure 1B ). Thus, ACT-PLZF hybrids likely mimic RARa-PLZF in their activity which prompted us to further examine their functional properties. The so-called KruÈppel-type Zinc-®ngers found in PLZF represent one type of characteristic structural elements identi®ed in DNA-binding proteins (Schuh et al., 1986) . Therefore the ACT-PLZF hybrids might speci®cally bind to upstream promoter sequences via the PLZF domain and induce reporter gene expression via the fused GAL4 activation domain ( Figure 1D ). To address this possibility, the GAL4-PLZF hybrids were expressed alone in two dierent indicator yeast strains, in which his3 and LacZ reporter genes are driven by lexA operator sequences (the L40 strain (Hollenberg et al., 1995) used in the initial two-hybrid screening) and GAL4 binding sites (Y190 (Harper et al., 1993) ) respectively. As shown in Figure 1C , transcriptional activation of the reporter genes, (i) was observed only with the GAL4-PLZF hybrids, (ii) was speci®c of the upstream element controlling the reporter genes, i.e. lexA operator sequences, (iii) did not depend on the coexpression of a LexA hybrid protein. Altogether these results suggest that the PLZF region common to the three GAL4-PLZF hybrids, namely the ®ve carboxyterminal Zinc-®ngers confer speci®c binding to a DNA target located upstream of the L40 reporter genes.
Speci®c in vitro binding of ACT-PLZF hybrids to upstream sequences of the L40 yeast strain reporter genes
The GAL4 and LexA-based reporter systems provided by the L40 and Y190 indicator yeast strains have been used widely in two-hybrid screens, suggesting comparable sensitivity of reporter activation in both systems. However the possibility that non-speci®c weak DNAbinding activity of ACT-PLZF hybrids could have been detected in the lexA-but not in the GAL4-based method could not be formally ruled out. It could also be argued that in vivo reporter gene activation by ACT-PLZF hybrids involved endogenous yeast proteins in addition to the basal transcription factors. To directly monitor speci®c DNA-binding activity of ACT-PLZF hybrids, we therefore performed electrophoretic mobility shift assays (EMSA) with in vitro-translated proteins.
The three ACT-PLZF inserts as well as an irrelevant ACT fusion insert (ACT-IR) were excised from the original pACTII (Harper et al., 1993) recombinant prey plasmid and subcloned into pcDNA3 vector (Invitrogen). The resulting recombinant plasmids were then used as templates in in vitro transcription-translation reactions. As shown in Figure  2a , the dierent ACT hybrid proteins showed the expected size and were synthesized in comparable amounts.
The upstream sequences of the his3 and lacZ reporter genes were retrieved from L40 strain by PCR using the¯anking oligonucleotides indicated in the original description of the yeast strain (Hollenberg et al., 1995) and subcloned into pBluescript vector (Stratagene). As shown in Figure 2b , the sequence consists of four tandem repeats of two distinct overlapping lexA operator motifs separated by a spacer of variable length. Figure 2c shows the results of an EMSA experiment performed with the corresponding double stranded labeled probe (8 OP) and various in vitro translated proteins. As expected, no probe mobility shift was observed with luciferase and ACT-IR (Figure 2c, lanes 1 and 2) . By contrast, each ACT-PLZF hybrid produced two prominent retarded bands. Furthermore the mobility of the complexes showed inverse relationship with the size of the hybrid protein used in the binding reaction (Figure 2c , lanes 3 ± 5). This indicated the presence of at least two PLZF binding sites within the probe. A slower migrating complex was also observed with ACT-PLZF 1 and 3 (Figure 2c, lanes 3 and 5) . These complexes which likely arise from simultaneous occupancy of the probe at three distinct sites, are detected as minor species (Figure 2c , lanes 3 ± 5) suggesting non-saturating amounts of in vitro translated proteins in the binding reactions.
Finally the possibility that binding of ACT-PLZF at several sites of 8 OP probe re¯ected non speci®c anity for DNA was excluded by another EMSA experiment including an irrelevant DNA probe (IR) similar in size to 8 OP. As shown in Figure 2d , speci®c mobility shifts in binding assays using ACT-PLZF1 was observed only with 8 OP probe (compare lane 4 to lane 2) and no speci®c complex was revealed with IR probe even after overexposure of the gel (lanes 3' and 4').
Altogether these results indicate that the three PLZF hybrids show comparable quantitative and qualitative DNA-binding activity and assign the PLZF DNAbinding domain to the 5 most carboxyterminal Zinc®ngers of the protein, a region retained in RARa-PLZF. Interestingly, a variant breakpoint in the PLZF gene leading to a RARa-PLZF fusion with only the 6 last Zinc-®ngers has been recently described . (Figure 2c  and d) , the tcgact motif present only twice in the probe cannot belong to the target site of PLZF. By contrast, the triplet TACT motif¯anking lexA op2 sequence could be part of the PLZF binding site. However, as discussed above, limiting amounts of protein in the binding assay can prevent the detection of complexes corresponding to more than three sites simultaneously occupied by PLZF molecules. Therefore, the possibility remained that motifs showing higher redundancy including the lexA operators themselves represent the PLZF binding sites.
To more precisely map the PLZF target sequence we ®rst deleted the two ®rst tandem repeats of overlapping lexA operator sequences from 8 OP probe generating the 4 OP probe (Figure 3a top) . In EMSA experiments using in vitro translated ACT-PLZF 1 protein, two S-labeled products of the indicated transcription-translation reactions (5% of total reaction) were separated on a 12% polyacrylamide gel and visualized by autoradiography. (b) Upstream sequence of the L40 reporter genes. Sequence presentation allows visualization of internal redundancy. Nucleotides more than twice redundant are indicated in uppercase letters and the longest motif present in three copies is represented in bold characters. The two overlapping lex A operator sequences are boxed. An end-labeled probe (8 OP) was synthesized by PCR using the oligonucleotides indicated by arrows. (c) In vitro binding of PLZF hybrids to 8 OP probe assayed by EMSA. End-labeled double stranded 8 OP probe (10 fmoles) was incubated with the indicated in vitro translated proteins (5% of total reaction) for 30 min at room temperature in binding buer (10 mM HEPES pH 7.9; 50 mM KCl; 2 mM MgCl 2 ; 2 mM dithiothreitol; 10% glycerol) in the presence of 1 mg/ml of dI:dC. The binding reactions were loaded on a 5% non-denaturing polyacrylamide gel in 0.5 X Tris/Borate buer and the dried gel autoradiographed. Position of free probe is indicated by an arrow. We next performed methylation interference assays (Siebenlist et al., 1980) in order to identify the guanines involved in DNA/PLZF interaction. Figure  3b shows that two methylated guanines close to the 3' end of the redundant probe region are signi®cantly excluded from bound probe. Quantitation using Phosphorimager analysis indicated that at these positions, the ratio of methylated guanines in bound over free probe was 0.3 and 0.4 for the 5' and 3' probe repeats, respectively. These values are in agreement with the 0.5 ratio expected for random occupancy of one of the two sites by PLZF. A similar experiment performed with the labeled complementary strand of the 4 OP probe revealed interference at another position located in between the two aforementioned Gs (data not shown) and altogether, these results indicate that the underlined nucleotides in the GTACAG motif are important for interaction with PLZF (Figure 3a top) .
We next analysed the ability of overlapping double stranded oligonucleotides derived from 4 OP probe sequence and containing the above motif to compete with labeled 4 OP probe for ACT-PLZF 1 binding. As shown in Figure 3a , the O1 oligonucleotide which contains the motif at its 3' end was not able to compete with 4 OP probe for PLZF binding (compare lanes 4 and 3). By contrast, the O2 and O3 oligonucleotides which extend 3' of the motif by including the TACT tetranucleotide, also redundant in 4 OP probe, readily bind to ACT-PLZF, as indicated by strong signal reduction at the position of retarded bands (Figure 3a ; compare lanes 5 and 6 to lane 3). Therefore, the minimal PLZF target sequence inferred from these experiments corresponds to the O3 oligonucleotide sequence which partially overlaps with lexA op2 operator sequence. Finally, a series of oligonucleotides divergent at one or two positions from O3 sequence was assayed for PLZF binding in competition assays summarized in Table 1 . As expected, mutations at positions identi®ed in methylation interference assays (oligonucleotides O5 and O6) strongly diminish or abolish the binding of PLZF. By contrast, substitutions in oligonucleotides O4 and O7 do not signi®cantly aect binding of PLZF.
Altogether, these data allow to delineate the following core target sequence, TATGTACAGTAC.
Li et al. reported the use of PCR selection for the determination of PLZF target site and mentioned a TAAA sequence as the selected core motif . Interestingly the same motif is present in the O1 and O6 oligonucleotides which do not bind PLZF, but absent in all competitor oligonucleotides ( Figure 3A and Table 1 ). Therefore, this motif is neither required nor sucient for high anity binding of PLZF in the context of 4 OP probe sequence. However, existence of distinct targets for a given DNA-binding protein has already been described (Hyde-De Ruyscher et al., 1995; and PLZF might recognize the TAAA motif in another context of surrounding nucleotides.
Transactivation properties of ACT-PLZF hybrids in human cells
High anity of PLZF for the 8 OP sequence predicts that ACT-PLZF hybrids should transactivate a 8 OP driven reporter gene not only in yeast but also in mammalian cells. The human Chang liver cell line was co-transfected with the pL8 CAT reporter plasmid in which the CAT reporter gene is placed under the control of the 8 OP sequence (Hollenberg et al., 1995) and pcDNA3 vector, either empty or carrying ACT-PLZF inserts. As illustrated in Figure 4 , signi®cant transactivation of the CAT reporter gene was reproducibly observed with ACT-PLZF 1 and with ACT-PLZF 2, but not with ACT-PLZF 3. The best transactivation eciency was obtained with the hybrid retaining only the ®ve carboxyterminal PLZF Zinc®ngers. By contrast, in yeast cells, ACT-PLZF 1 did not induce higher reporter gene activation than the two other hybrids (data not shown). This suggests that in mammalian cells, folding of the hybrid protein may in¯uence its transactivation properties. In addition, the domain N-terminal to the Zinc-®nger region in ACT-PLZF 3 might repress transcription initiation in mammalian cells since in 3/4 transient transfection assays, CAT activity in the presence of the hybrid protein was below the basal level observed with empty pcDNA3 (Figure 4) . In any case, our data demonstrate that the PLZF Zinc-®nger domain behaves as a speci®c transcriptional transactivator in human cells, when fused to a heterologous transactivation domain.
Concluding remarks
Starting from a yeast two-hybrid screening experiment, we were able to identify a speci®c DNA target of PLZF and assign the DNA-binding domain to the last ®ve Zinc-®nger region of the protein. These observations call comments with respect both to the methodology used and to their implications for the physiopathology of APL disease.
The yeast two-hybrid method is an assay of in vivo protein-protein interaction (Fields and Song, 1989) which is now widely used for the identi®cation of proteins (prey proteins) speci®cally interacting with a protein of interest (bait protein). Therefore, positive clones that do not show speci®city with regard to the bait protein are usually not further characterized. However, among prey plasmids falling in this class, one expects some to be true autonomous hybrid transcription factors. The ACT-PLZF plasmids described here exemplify this kind of two-hybrid preys. The corresponding proteins are obtained by their ability to activate the reporter genes via direct binding to their upstream DNA sequences ( Figure  1D ), as opposed to the preys which require proteinprotein interaction to do so. In this case, the yeast genetic screening has selected for DNA-protein interaction, a possibility which is directly exploited in the`one hybrid' assay (Inouye et al., 1994) . In this method, the target sequence of interest drives the expression of the yeast reporter genes which allows selection for the protein binding to the DNA bait. Given the low abundance of PLZF mRNA in adult liver (Chen et al., 1993) the genetic selection appears to be powerful and one may predict that other proteins binding to the upstream sequences of the yeast reporter genes can be identi®ed. The present work provides a simple strategy to characterize such proteins. The minimal region responsible for DNAbinding activity can be simply inferred from sequencing analysis of independent inserts. Further subcloning of the fusion inserts into a versatile expression vector such as pcDNA3 allows analysis of DNAprotein interactions both in vitro, using in vitro translation, and in vivo, following transient transfection into mammalian cells. Licht et al. showed that PLZF-RARa and PMLRARa are very similar with regard to interference with RARa normal function and suggested that a dominant eect of RARa-PLZF chimeric protein might account for the distinct refractory behavior of t(11;17) APL to both chemotherapy and ATRA (Licht et al., 1996) . The present ®nding that RARa-PLZF has retained the DNA-binding domain of native PLZF is consistent with this hypothesis and in turn suggests that PLZF activity is quantitatively and/or qualitatively aected in the context of the hybrid gene. Supporting this view, the PLZF gene appears to be down-regulated during normal myeloid dierentiation (Reid et al., 1995) whereas expression of the RARa-PLZF chimeric gene is driven by the active RARa gene promoter, shown to be further stimulated by ATRA . In addition, normal eector function of Zinc®nger proteins such as the Wt1 tumor suppressor gene can be active transcriptional repression of their cognate targets (Drummond et al., 1992; Madden et al., 1991) and Li et al. reported the existence of a putative repression domain in the N-terminal region of PLZF . Thus, RARa-PLZF appears to represent more than the simple mechanical result of the balanced t(11;17) translocation since it might lead to inappropriate expression of PLZF target genes. Identi®cation of these targets will contribute to the understanding of APL etiology and might be facilitated by the present description of a speci®c PLZF DNAbinding site.
